9.42
9.42 (0%)
As of May 12, 2025
Optinose, Inc. [OPTN]
Source:
Company Overview
Optinose, Inc. is a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. Our first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing our proprietary Exhalation Delivery System that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
Country | United States |
Headquarters | yardley, pennsylvania |
Phone Number | (267) 364-3500 |
Industry | manufacturing |
CEO | Ramy Mahmoud |
Website | www.optinose.com |